IRONDisc Medicine, Inc.
Is it safe?
Caution warranted: heavy debt (BB) and big price swings.
Insiders were net sellers (-$12.7M, 90 days to Oct 8, 2026), selling is often routine.
Net cash, but unprofitable, speculative. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -97% · now 34% below its 52-week high.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can IRON take a bad year?
Disc Medicine, Inc. holds $658M more cash than debt, and is burning $49M a quarter, about 3.6 years of cover.
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Cash runway
- 3.6 years
Cash runway · burning $49M a quarter at the current rate
- Annualised volatility
- 54%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtQ2 2026
- $59M
- Cash and short-term investments
- $718M
- Net cash
- $658M
- EBITDA, trailing twelve months
- −$269M
- Operating profit, trailing twelve months
- −$269M
- Debt / equity
- 0.09×
- Annualised volatilitytwo years of daily moves
- 54%
- Worst drawdown on file
- −97%
- Below its 52-week high
- 34%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.